HYDRALAZINE HYDROCHLORIDE
Generic: HYDRALAZINE HYDROCHLORIDE
Basic Information
Manufacturer
HF Acquisition Co LLC, DBA HealthFirst
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAMUSCULAR
FDA Set ID
94530e4d-b1c0-6171-e053-2a95a90a05fa
Indications & Usage
Indications & Usage Severe essential hypertension when the drug cannot be given orally or when there is an urgent need to lower blood pressure.
Warnings
Warnings In a few patients hydralazine may produce a clinical picture simulating systemic lupus erythematosus including glomerulonephritis.
In such patients hydralazine should be discontinued unless the benefit-to-risk determination requires continued antihypertensive therapy with this drug.
Symptoms and signs usually regress when the drug is discontinued but residua have been detected many years later.
Long-term treatment with steroids may be necessary (see PRECAUTIONS, Laboratory Tests).
In such patients hydralazine should be discontinued unless the benefit-to-risk determination requires continued antihypertensive therapy with this drug.
Symptoms and signs usually regress when the drug is discontinued but residua have been detected many years later.
Long-term treatment with steroids may be necessary (see PRECAUTIONS, Laboratory Tests).
Adverse Reactions
Adverse Reactions Adverse reactions with hydralazine hydrochloride are usually reversible when dosage is reduced.
However, in some cases it may be necessary to discontinue the drug.
The following adverse reactions have been observed, but there has not been enough systematic collection of data to support an estimate of their frequency.
Adverse Reactions
However, in some cases it may be necessary to discontinue the drug.
The following adverse reactions have been observed, but there has not been enough systematic collection of data to support an estimate of their frequency.
Adverse Reactions